MYMihriban Yücel

Mihriban Yücel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mihriban Yücel has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A case developing Candida auris related candidaemia following multiple drug-resistant Klebsiella pneumoniae meningitis after neurosurgical intervention

    by Oğuzhan Yıldız, Melike Ersoy, Seda Karataş, Metin Özsoy, Mehmet Emre Yıldırım, Mihriban Yücel, Serap Yağcı, Rukiye Berkem, Nilgün Karabıçak, Salih Cesur, et al.

    A 28-year-old man who underwent ventriculoperitoneal shunt (VPS) operation at another medical center due to epidural abscess and hydrocephalus was admitted due to deterioration of his general condition. WBC count was 9360/mm³, C-reactive protein (CRP) was 54 mg/L (normal range <5 mg/L) and glomerular filtration rate was 150 ml/min, while the results of other laboratory tests were nonspecific. He was receiving vancomycin and meropenem treatment. Urine cultures were taken during hospitalization and again 48 hours later and Candida auris (C. auris) growth of 105 cfu/ml was detected. On the 4th day of hospitalization, the patient was intubated due to decreased oxygen saturation, and while under meropenem and vancomycin treatment, carbapenem-resistant, gentamicin and ceftazidime-avibactam-susceptible and multidrug-resistant Klebsiella pneumoniae growth was detected in CSF culture. The patient's ventriculoperitoneal shunt was removed and hydrocephalus was followed with extra-ventricular drainage (EVD). Vancomycin treatment was discontinued and intrathecal (IT) gentamicin treatment was started. Due to the susceptibility of Klebsiella pneumoniae growth from deep tracheal aspirate to ceftazidime-avibactam, antibiotic treatment was changed to intravenous (IV) meropenem, IV ceftazidime-avibactam and IT gentamicin and treatment was continued for 10 days. No growth was detected in CSF culture obtained under treatment. On the 20th day of hospitalization due to deterioration of his clinical condition under treatment, tracheostomy was performed, he was intubated, blood and urine cultures were repeated and C. auris growth was detected in blood culture on the 27th day after hospitalization using VITEK MS MALDITOF (bioMérieux, France) microbiological identification system. Confirmation of the C. auris species and antifungal susceptibility testing was performed by the Mycology Reference Laboratory, Institute of Public Health and antibiotic treatment was stopped. According to the antifungal susceptibility test results, the patient was started on anidulafungin. In conclusion, nosocomial C. auris infection should be considered in patients with underlying predisposing factors such as long intensive care unit stays, broad-spectrum antibiotic use, surgical interventions, central venous catheter use, intubation and infection due to gram-negative bacteria.

  • The Change in Antimicrobial Resistance During the COVID-19 Pandemic in Türkiye

    by Nisel Yılmaz, Gülşen Altınkanat Gelmez, Güner Söyletir, Arzu İlki, Aynur Eren Topkaya, Ayşe İstanbullu Tosun, Devrim Dündar, Duygu Öcal, Ebru Evren, Erdal Özbek, et al.

    Antimicrobial resistance (AMR) is one of the most important problems threatening human health worldwide. The impact of the Coronavirus disease-2019 (COVID-19) pandemic on AMR continues to be discussed. Some researchers argue that the pandemic will increase AMR rates, while others suggest the opposite. The aim of this study was to investigate the change in AMR of Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains in three cross-sectional periods in Turkiye, the first one before the COVID-19 pandemic, the second and the third one during the pandemic. The change in antibiotic susceptibility in Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains isolated from urine, blood, and lower respiratory tract samples of patients hospitalized in intensive care units and wards of hospitals before (November 2019) and during the COVID-19 pandemic (November 2020 and July 2021) was investigated in this study. A total of 17 voluntary hospitals, members of the Antibiotic Sus- ceptibility Surveillance Study Group (ADSI) of the Society for Clinical Microbiology Specialists (KLIMUD), participated in the study. Identification of bacteria was performed with automated bacterial identification systems (VITEK2, bioMerieux, France or Phoenix, BD, USA). Antibiotic susceptibility tests were performed in one center with the Kirby-Bauer disc diffusion method and in other centers with automated antibi- otic susceptibility test systems (VITEK2, bioMerieux, France or Phoenix, BD, USA), and the results were evaluated according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. Antibiotic susceptibility ratios were statistically analyzed using either the chi-square or Fisher's exact test. A p-value of < 0.05 was considered statistically significant. Antibiotic susceptibility test results of a total of 4030 strains; 1152, 1139, and 1739 belonging to November 2019, November 2020, and July 2021, respectively; were examined. While cefotaxime and ceftazidime susceptibility rates in E.coli strains increased during the pandemic period compared to previous period (p= 0.04, p= 0.001, respectively); nitrofurantoin sensitivity (p= 0.02) and extended-spectrum beta-lactamase (ESBL) ratios (p< 0.001) were found to be decreased. It was determined that the susceptibility rates of all other examined antimicrobials did not change statistically. It was observed that the susceptibility rates of all antibiotics in K.pneumoniae isolates decreased during the pandemic period, but the ESBL rates increased between 2019-2020 (p= 0.01) and decreased between 2020-2021 (p= 0.02). It was found that ESBL rates increased before and after the pandemic. It was observed that the susceptibility to ciprofloxacin (p= 0.0001), levofloxacin (p= 0.003), and gentamicin (p= 0.005) in S.aureus strains increased during the pandemic period. No significant changes were observed in other antibiotic susceptibility rates. Methicillin resistance of S.aureus (MRSA) strains decreased between 2019-2020 (p= 0.03) and increased again in 2021 (p= 0.04) and returned to the pre-pandemic rate. Our study results suggest that the measures taken to reduce the spread of COVID-19 with the pandemic (such as quarantine practices, increased hand hygiene, mask use, and national/international travel restriction) may reduce the spread of bacteria such as ESBL-producing E.coli and the rate of MRSA, which is considered as a hand hygiene indicator. The increase in the later stages of the pandemic recalls the relaxation in compliance with hand hygiene rules. The decrease in the susceptibility rate of K.pneumoniae isolates to antibiotics and the increase in the ESBL rate may be due to inappropriate and excessive use of antibiotics during the pandemic period. However, we believe that these data should be supported by studies to be conducted nowadays when all the rules and measures are back as if the pandemic has ended.


  • Open Access

    Exploring the antibiotic susceptibility of nosocomial infection causative Corynebacterium striatum strains

    by Çiğdem Ataman Hati̇poğlu, Salih Cesur, Esra Kaya Kılıç, Sevgül Usanoğlu, Fatma Şebnem Erdi̇nç, Günay Tuncer Ertem, Sami Kınıklı, Mihriban Yücel, Serap Yağci

    Introduction: Corynebacterium striatum (C. striatum) is one of the most frequently reported nosocomial infection agents among patients hospitalized in intensive care units following the COVID-19 pandemic. It may cause various opportunistic infections, such as ventilator-associated pneumonia and catheter-associated bloodstream infections, in such patients. The present study attempted to investigate the antibiotic susceptibility of 14 nosocomial infection agent C. striatum strains, isolated from deep tracheal aspirate and blood culture samples of hospitalized patients, for seven different antibiotics (benzylpenicillin, ciprofloxacin, clindamycin, rifampicin, linezolid, tetracycline, and vancomycin). Material and Method: Antibiotic susceptibility of the strains for the mentioned antibiotics was determined utilizing a disk diffusion test in line with the recommendations of the European Antibiotic Susceptibility Committee (EUCAST). Results: While all the isolated C. striatum strains (100%) were resistant to benzylpenicillin, tetracycline, rifampicin, ciprofloxacin, and clindamycin, we found none of them to be resistant to vancomycin and linezolid. Conclusion: Overall, uncovering the antibiotic susceptibility of C. striatum strains isolated from clinical specimens would guide clinicians in deciding on the empirical treatment of hospital-acquired infections led by this agent.

  • Karbapenemaz Üreten Enterobacteriaceae ile Rektal Kolonizasyon için Risk Faktörleri

    by Şirin Hekimoğlu, Günay Ertem, Mihriban Yücel, Hülya Başar, Esra Kaya Kılıç, Ayşe Özcan, Fatma Şebnem Erdinç, Necla Tülek

  • Evaluation of EUCAST Direct Rapid Antimicrobial Susceptibility Test Method in Blood Culture Bottles with Positive Signal

    by Gizem Erdoğan, Ayşe Esra Karakoç, Mihriban Yücel, Serap Yağcı

    Early reporting of the antibiotic susceptibility testing (AST) results is essential for the survival of sepsis patients. In 2019, European Committee on Antimicrobial Susceptibility Testing (EUCAST) published a proposal to detect antimicrobial susceptibility from positive blood culture bottles with a rapid antimicrobial susceptibility test (RAST) method in a maximum of eight hours. In this study, it was aimed to evaluate the EUCAST RAST method in blood culture bottles that resulted with positive signal in BacT/ALERT (bioMerieux, France) blood culture system and that showed gram-negative bacteria with single morphology with Gram stain. The study was conducted prospectively between April 2019 and November 2019. Ninety blood culture bottles that we detected single gram negative bacteria morphology by Gram stain were tested according to the EUCAST RAST method, The isolates obtained from the blood culture bottles were studied with the EUCAST disk diffusion method and the Vitek 2 Compact (bioMerieux, France) automated system. The results obtained with RAST were compared with the results of these methods. The turn around time of the RAST method was recorded. Categorical agreement of the RAST method with conventional methods and the very major error rates were determined. Of the 14 isolates not yet covered by the EUCAST HADT method, 12 were determined to be other Enterobacterales members and two as other non-fermentatives. Two isolates were detected with the same morphological characteristics in Gram stain of the blood culture bottle and the same antibiotic susceptibility profile, but with different identification results. These sixteen isolates were excluded from the study. In this study the susceptibility of 74 isolates were determined according to the EUCAST breakpoint tables, of which 31 were Klebsiella pneumoniae, 35 were Escherichia coli, four were Acinetobacter baumannii and four were Pseudomonas aeruginosa. According to the evaluation periods of EUCAST RAST; the susceptibility profile was reported for nine (12%) of E.coli at four hours, eight (11%) at six hours, 18 (24%) at eight hours; three (4%) of K.pneumoniae at four hours, 16 (21%) at six hours, 12 (16%) at eight hours; three of P.aeruginosa (4%) at six hours, one (1%) at eight hours; two of A.baumannii (2%) at six hours and two (2%) at eight hours. The categorical aggrement of the RAST method was 91.8% with the automated system and 96.8% with the disc diffusion method. Very major errors of RAST method compared to the automated system were detected for piperacillin-tazobactam (17.7%), ceftazidime (11.6%) and meropenem (5.6%); and when compared to the disc diffusion method, for cefotaxime (5.7%) and meropenem (6.7%). Our results have shown that EUCAST RAST method can practicaly be performed in routine laboratories to report early results with a low cost. Because of the very major errors it is necessary to confirm the results with the standard methods.


  • A case of Peritonitis Caused by Wickerhamomyces anomalus (Candida pelliculosa) Related to Peritoneal Dialysis

    by Kübra Evren, Eda Akçay, Mihriban Yücel, Ayşe Zeynep Bal, Fatma Şebnem Erdinç, Bedia Dinç, Ayşe Kalkancı

    Fungal peritonitis is less commonly seen than bacterial peritonitis in patients undergoing peritoneal dialysis (PD), but it is a serious complication with high morbidity and mortality. It often results in catheter loss and modifying therapy from PD to hemodialysis. The causative organisms are often Candida species. In this report, a PD-associated peritonitis caused by Wickerhamomyces anomalus (Candida pelliculosa), a rare fungal infection agent with increasing clinical importance by causing different clinical pictures was presented. An outpatient peritoneal fluid culture was sent from a 48-yearold male patient, who had been undergoing continuous peritoneal dialysis (CAPD) for 9 years, due to abdominal pain and blur in peritoneal fluid during dialysis. The patient admitted to the emergency department four days later due to the persistence of his complaints. A sample of peritoneal fluid was taken in the emergency department and sent to the laboratory for microbiological analysis. In the direct microscopical examination of the peritoneal fluid; cell number was determined as 210/mm3, and no microorganisms were seen in the Gram and methylene blue staining. The patient was admitted to the nephrology service with a pre-diagnosis of PD-associated peritonitis. Enterobacter aerogenes was grown in the peritoneal fluid culture which was sent from the dialysis outpatient clinic four days ago. The peritoneal fluid sample sent from the emergency department was inoculated on 5% sheep blood , EMB and chocolate agars and no growth was detected. As the patient's complaints and peritoneal fluid leukocyte count continued to increase, peritoneal fluid cultures were repeated and recurrent growth of yeast was detected in cultures. The yeast was identified as Candida pelliculosa by matrix assisted laser desorption ionization time-of-flight mass spectrofotometry (MALDI-TOF) VITEK®MS (bioMerieux, France). The species identification was confirmed by sequencing the target ITS gene regions on the rRNA and the isolate was identified as 100% Wickerhamomyces anomalus (sexual reproduction form of Candida pelliculosa, teleomorph). The reference microdilution method was performed according to the recommendations of the Clinical and Laboratory Standards Institute (CLSI) in order to test the antifungal susceptibility. After 24 hour incubation, the minimal inhibitory concentrations (MIC) were determined as 0.03 μg/ml for amphotericin B, 0.125 μg/ml for caspofungin 0.125 μg/ml for voriconazole, 0.03 μg/ ml for itraconazole and 4 μg/ml for fluconazole. Fluconazole and anidulafungin were started for the treatment of fungal peritonitis. The patient's peritoneal dialysis catheter was removed and hemodialysis was applied to the patient. Clinical and laboratory symptoms regressed with antifungal therapy and the patient's anidulafungin treatment was discontinued for 14 days after the catheter removal. In conclusion, in patients undergoing CAPD, as in our case, fungal pathogens should also be considered although it is rare, when there is no laboratory and clinical improvement, and the response to treatment is not complete in PD-associated peritonitis to prevent delays in diagnosis and treatment.


  • Karbapenemaz üreten Enterobactericea üyelerinin saptanmasında CHROMagar besiyeri ile RAPIDEC ® CARBA NP testin performansının karşılaştırılması

    by Şerife Altun Demi̇rCan, Esra Kaya Kiliç, Sami Kinikli, Salih Cesur, Serap Yağci, Mihriban Yücel, Cigdem Ataman Hati̇pOglu, Bedia Di̇nÇ

    Amaç: Karbapenemaz üreten Enterobactericea (CPE) üyeleri ülkemizde ve dünyada önemli bir sağlık bakımıyla ilişkili infeksiyon etkenidir ve saptanmaları güçlük gösterir Bu çalışmanın amacı; karbapeneme dirençli Enterobactericea üyelerini saptamada yeni bir kromojenik besiyeri olan CHROMagar CARBA ID ve OXA-48 besiyerleri ile RAPIDEC ® CARBA NP testin performansının karşılaştırılmasıdır Gereç ve Yöntem: Çalışmaya Ankara Eğitim ve Araştırma Hastanesi Yoğun Bakım ünitesinde yatan hastaların çeşitli klinik örneklerinden (Derin trakeal aspirat, kan, idrar vb.) izole edilen ve karbapenem direnci fenotipik olarak disk difüzyon ve otomatize sistemle (Vitek 2) ile saptanan 67 Enterobactericea suşu ( 30 E.coli, 37 Klebsiella pneumoniae) dahil edildi. İzole edilen 67 suşun disk difüzyon yöntemi ve VITEK-2 otomatize sistemi ile 28’inin (% 42) karbapeneme duyarlı , 39’unun (%58) ise karbapeneme dirençli olduğu saptandı. Şuslar eş zamanlı olarak CHROMagar CARBA ID ve OXA-48 besiyerlerine ekildi. Suşlar 37 ⁰C ‘de etüvde 24-72 saat süreyle inkübe edildi. Renk değişimleri 24,48 ve 72. saatlerde değerlendirildi. İzole edilen suşlarda RAPIDEC ® CARBA NP testi de çalışılarak kromojenik agar besiyerleri ile performansları karşılaştırıldı. RAPIDEC ® CARBA NP testi üretici firmanın önerileri doğrultusunda çalışıldı. Her iki yöntemin karşılaştırılmasında disk difüzyon ve otomatize sistemle (Vitek 2) ile saptanan karbapenem direnç sonuçları referans olarak kabul edildi. Bulgular: Toplam 67 izolatın , disk difüzyon ve VITEK 2 otomatize sistemle 28 (%42)’inin karbapeneme duyarlı, 39 (%58)’unun ise karbapeneme dirençli olduğu belirlendi. Disk difüzyon yöntemi ve VITEK 2 otomatize sistemi referans alındığında; Rapidec CARBA ® NP testin uyum oranı %93 (62/67) iken, kromojenik besiyerleri (CHROMID CARBA ve OXA-48) ile disk difüzyon yöntemi ve VITEK 2 yöntemi arasındaki uyum oranı %75 (50/67) idi. Disk difüzyon yöntemi ve VITEK 2 otomatize sistemi referans alındığında kromojenik CARBA ID ve OXA-48 besiyerleri ile RAPIDEC ® CARBA NP testi arasındaki uyum oranı %69 (46/67) olarak belirlendi. Sonuç: Karbapeneme dirençli Enterobactericea ailesi üyelerinin saptanmasında fenotipik yöntemlerin performansının değerlendirilmesi için bu testlerin referans yöntem olan genotipik testlerle karşılaştırıldığı daha fazla sayıda suş içeren in vitro çalışmalara ihtiyaç olduğu görüşündeyiz.

  • Pneumococcal carriage in children with COVID-19

    by Kubra Aykac, Yasemin Ozsurekci, Burcu Ceylan Cura Yayla, Kubra Evren, Sibel Lacinel Gurlevik, Pembe Derin Oygar, Mihriban Yucel, Ayse Esra Karakoc, Alpaslan Alp, Ali Bulent Cengiz, et al.

    Background: SARS-CoV-2 is the new virus, and Streptococcus pneumoniae is one of the most important pathogens affecting humans. However, we do not yet know whether these microorganisms interact. Thus, we aimed to evaluate the relationship between Streptococcus pneumoniae and SARS-CoV-2 in pediatric patients. Methods: This study was conducted retrospectively by means of medical records of pediatric patients who were tested for SARS-CoV-2 between March 11 and June 04, 2020, in the University of Health Sciences, Ankara Educating and Training Hospital and Hacettepe University Faculty of Medicine. Results: We evaluated 829 pediatric patients for S. pneumoniae and SARS-CoV-2 from their nasopharyngeal specimen. Of 115 children positive for SARS-CoV-2, 32.2% had a positive S. pneumoniae test, whereas of 714 children negative for SARS-CoV-2, 14.1% had a positive S. pneumoniae test (p < .01). We compared patients with positive vs. negative SARS-CoV-2 tests according to S. pneumoniae positivity There were no statistically significant differences in terms of gender, underlying disease, fever, cough, leukocytosis, lymphopenia, increased CRP, increased procalcitonin, findings of chest x-ray, severity of disease, and treatment. Conclusion: The nasopharyngeal S. pneumoniae carriage rate in patients with COVID-19 was higher than in non-infected children, while S. pneumoniae carriage did not affect the course of COVID-19 disease. Pneumococcal vaccination is significant, such that we do not know the outcomes of increased pneumococcal carriage for the upcoming months of pandemic.


  • Comparison of non‐invasive tests with invasive tests in the diagnosis of celiac disease

    by Yasemin Derya Gülseren, Ali Kudret Adiloğlu, Mihriban Yücel, Zuhal Dağ, Nilnur Eyerci, Rukiye Berkem, Levent Filik, Muzaffer Çaydere

    Background/Aims: Today, invasive diagnostic tests are necessary for definite diagnosis of adult celiac disease (CD). However, in selected children patients, the need for invasive tests is ceased. In this study, we evaluated adult patients according to the ESPGHAN (European Pediatric Gastroenterology Hepatology and Nutrition Society) criteria.Methods: Thirty‐nine patients (aged 17‐66) with symptoms of CD were included. Serum samples were tested for total IgA, tTG‐IgA (antitissue transglutaminase), tTG‐IgG, DGP‐IgA (antideamidated gliadin peptide), DGP‐IgG, and EMA (endomysial antibodies). HLA‐DQ typing was studied with PCR‐SSP (sequence‐specific primers) method. Biopsy samples were evaluated according to Marsh scoring.Results: In CD patients, 71.4% (15/21) of the patients were diagnosed without biopsy according to the EPSGHAN criteria but when ESPGHAN's IgA tTG threshold value for children was taken into consideration (>200 IU/mL), the sensitivity decreased to 81%. Celiac disease diagnosed and control groups were compared in terms of HLA tissue types. DQ2.5 homozygous or DQ2.5/DQ2.2 was significantly higher in CD group, and DQ2‐ or DQ8‐negative HLA tissue type was significantly higher in control group.Conclusion: When serological tests, HLA typing, and clinical symptoms are all in favor of CD, biopsy may not be performed in selected adult CD patients.